The sodium channel Na v 1.7 is preferentially expressed in nociceptive neurons and is believed to play a crucial role in pain sensation. Four alternative splice variants are expressed in human dorsal root ganglion neurons, two of which differ in exon 5 by two amino acids in the S3 segment of domain I (exon 5A and 5N). Two others differ in exon 11 by the presence (11L) or absence (11S) of an 11-amino-acid sequence in the loop between domains I and II, an important region for PKA regulation. In the present study, we used the whole-cell configuration of the patch clamp technique to investigate the biophysical properties and 8Br-cAMP modulation of these splice variants expressed in tsA201 cells in the presence of the 1 -subunit. The alternative splicing of Na v 1.7 had no affect on most of the biophysical properties of this channel, including activation, inactivation, and recovery from inactivation. However, development of inactivation experiments revealed that the isoform containing exon 5A had slower kinetics of inactivation for negative potentials than variant containing exon 5N. This difference was associated with higher ramp current amplitudes for isoforms containing exon 5A.
Introduction
Voltage-gated sodium channels play a critical role in electrical signaling in the nervous system and are responsible for the initiation and propagation of action potentials.
They are composed of one -subunit (260 kDa), which forms the core of the channel and is responsible for the voltage-dependent gating and ion permeation (2; 5; 16) and auxiliary -subunits. The -subunit is composed of four homologous domains (DI-DIV), each with six -helical transmembrane-spanning segments (S1-S6). To date, ten mammalian -subunit isoforms have been identified, at least seven of which are expressed in the nervous system. Na v 1.1, Na v 1.2, Na v 1.3, and Na v 1.6 are predominantly expressed in the central nervous system, whereas Na v 1.7, Na v 1.8, and Na v 1.9 are mainly found in the peripheral nervous system (25). Two of these Na + channels predominate in small nociceptive sensory neurons, a fast inactivating TTX-sensitive channel (Na v 1.7)
and a slow inactivating TTX-insensitive channel (Na v 1.8), and have been cloned from peripheral sensory nerves.
Na v 1.7 may play an important role in nociceptive pain processing (40) . Numerous distinct homozygous nonsense mutations in Na v 1.7 have been identified in patients with a rare congenital disease that causes a complete inability to sense pain in otherwise healthy individuals (1; 8). All mutations described thus far cause a loss of function of this channel. Moreover, a chronic inflammatory dominant human disease, primary erythromelalgia, has been linked to Na v 1.7 mutations (11; 19; 21; 41) , indicating that this channel may play an important role in inflammatory pain. These studies strongly suggest that Na v 1.7 is essential for nociception in humans.
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Alternative splicing is a mechanism for generating a versatile repertoire of functionally different proteins from a common gene. This mechanism has been observed to occur at five sites for several -subunits encoding voltage-gated Na + channels from different species (13; 20; 26; 36) . More specifically, we focused on alternative splicing at two positions of mammalian sodium channel -subunit genes. The first position is in exon 5, which encodes part of segment S3 and all of S4 of domain I in neuronalsubunits. This splicing event produces the 5N or 5A splice forms, which have been described for Na v 1.2 (17; 32), Na v 1.3 (17) and Na v 1.6 (28; 30) . The two splice variants differ by either one or two amino acids. Transcripts containing exon 5N predominate in fetal and neonatal brain tissue, whereas in adult brain tissue, the predominant transcripts contain exon 5A. The second position for alternative splicing is in exon 11, which encodes the cytoplasmic loop connecting sodium channel transmembrane domains I and II. This splicing event produces a long (11L) and a short version (11S). Variations in the length of the encoded loop have been observed in Na v 1.1 (33) , Na v 1.3 (33; 37), and Na v 1.6 (28-30) .
Both alternative splicing events have also been described for Na v 1.7 in human dorsal root ganglia (DRG) neurons (30) . For this channel, exon 5A and 5N differ by two amino acids in the S3 membrane-spanning segment of domain I (exons 5A and 5N; D1S3:L201V and D1S3:N206D, respectively). In exon 11, two other splice variants are characterized by the presence (11L) or the absence (11S) of an 11-amino acid-sequence (VIIDKATSDDS) in the DI-DII linker (see Figure 1A , B). The two splicing events can produce four different Na v 1.7 isoforms: 5N11S, 5A11L, 5N11L, and 5A11S.
Interestingly, Raymond et al. (2004) (30) , who also monitored alternatively spliced However, the functional significance of this splicing is not known.
To understand the functional effects of this alternative splicing and its possible consequences in different pain states, we characterized the biophysical properties of each isoform. Since exon 11 is located in a region known to be important for sodium channel phosphorylation by protein kinase A (PKA), we also investigated the effects of cAMP on the Na v 1.7 splice variants.
Page 5 of 44

Materials and Methods
Construction of expression plasmids
A functional human Na v 1.7 cDNA clone (5N11S splice variant) assembled from overlapping PCR fragments (amino acid sequence corresponding to NM_002977) and inserted in a cRNA in vitro transcription vector, pKGEM (Jay Aiyar, unpublished) was used as the starting material to generate the 5A11S, 5N11L, and 5N11S splice variants.
Unique KpnI and XhoI restriction sites were inserted into the multiple cloning site of pKGEM to allow the transfer of Na v constructs to other vectors (Leif Dahllund, unpublished).
The 5A splice variant was generated by replacing two codons in 5N
(corresponding to D1S3:L201V and D1S3:N206D) by site-directed mutagenesis (QuikChange® II Site-Directed Mutagenesis Kit, Stratagene) using the following two oligonucleotides:
5'-GTTTTTGCGTATGTAACAGAATTTGTAGACCTAGGCAATGTTTCAGC-3' and 5'-GCTGAAACATTGCCTAGGTCTACAAATTCTGTTACATACGCAAAAAC-3'.
The 33 bp 11L insertion was generated by assembling two PCR fragments containing the extra bases in the oligonucleotide sequence. One of the fragments contained the 11L insertion at the 3' end while the other fragment contained the insertion at the 5' end. A unique SpeI site was inserted into the 33 bp fragment, without altering were verified by DNA sequencing of both strands.
Transfection of tsA201 cell line
tsA201 is a mammalian cell line derived from human embryonic kidney HEK 293 cells by stable transfection with SV40 large T antigen (23) . Cells were grown in high glucose DMEM supplemented with fetal bovine serum (10%), L-glutamine (2 mM), penicillin (100 U/ml), and streptomycin (10 mg/ml) (Gibco BRL Life Technologies, Burlington, ON, Canada). The cells were incubated in a 5% CO 2 humidified atmosphere.
The tsA201 cells were transfected using the calcium phosphate method as previously described (23) . CD8-a), as previously described (23) . The unattached beads were removed by washing with extracellular solution.
Patch clamp experiments
Macroscopic currents from transfected tsA201 cells were recorded using the whole-cell configuration of the patch clamp technique. The measurements were carried out at room temperature ( 22°C Devices). When appropriate, linear leak currents and capacitance artifacts were removed using P/N leak subtraction. Sodium currents were filtered at 5 kHz and digitized at 200 kHz. The digitized currents were stored on a computer for later off-line analysis.
Sodium currents were generated from a holding potential of -140 mV and depolarized to potentials ranging from -90 mV to 50 mV for 50 ms in 5 mV increments with 5 s stimulus intervals. The voltage dependence of activation was determined from the relative membrane conductance as a function of potential using the formula G Na =I Na /(V m -V rev ), where G Na is peak conductance, I Na is peak sodium current for the test potential V m , and V rev is the apparent reversal potential of the sodium current. The resulting sodium ion conductance was normalized to the maximum response for each cell. The voltage-dependence of inactivation was obtained by measuring the peak Na + current during a 20 ms test pulse to -20 mV, which followed a 500 ms pre-pulse to membrane potentials between -150 and -10 mV from a holding potential of -150 mV.
Peak inward currents were measured and normalized to the maximum response of each cell. The activation and inactivation data were fitted with a Boltzman equation, where V 1/2 and K represent, respectively, the half-maximum voltage of activation and inactivation and the slope factor:
, and I max represents the maximum current. The decay time constants were obtained by fitting a single exponential to the current traces. Deactivation was measured using a short (0.5 ms) depolarizing pulse to -20 mV followed by a 20 ms repolarizing pulse to potentials ranging from -100 mV to -40 mV ( 5 mV). Decaying current was then fitted with a single exponential function.
Recovery from inactivation was determined using a paired-pulse protocol in which the time between pulses varied. First and second pulses were a step depolarization from a holding potential of -140 mV to -20 mV with duration of respectively 50 ms and 20 ms.
Inter-pulse potential duration were increased in length from 0.5 ms to 1500 ms at a holding potential of -140 mV. Second pulse peak currents were then normalized to first pulse peak currents and plotted as function of inter-pulse time. Data were fitted with a simple exponential. To measure frequency dependent inhibition, a train of fifty -20 mV pulses was applied at frequencies of 5, 10, 20, 50, and 100 Hz. The peak current elicited by the 50th test pulse was normalized to the current of the first pulse (P 50 /P 1 ) and was 
Solutions and reagents
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The patch pipettes were filled with (mmol.l -1 ): 35 NaCl, 105 CsF, 10 EGTA, and 10 HEPES. The pH was adjusted to 7.4 using CsOH. The bath solution contained (mmol.l -1 ): 150 NaCl, 2 KCl, 1.5 CaCl 2 , 1 MgCl 2 , 10 glucose, and 10 HEPES. The pH was adjusted to 7.4 using NaOH. A -7 mV correction of the liquid junction potential between the patch pipette and the bath solutions was performed. For the PKA phosphorylation studies, the cells were held in the bath solution containing 1 mM 8Br-cAMP (Sigma) for 15 min prior to the experiments. To monitor the effect of 8Br-cAMP on current amplitude, the cells were held in the standard bath solution and perfused with a control solution (standard bath solution) to measure the control I-V curve. Then, the same solution containing 1 mM 8Br-cAMP was applied to the cell using a microperfusion system. Recordings were taken on a single cell before and during exposure to 8Br-cAMP.
Data analysis
The data were analyzed using a combination of pCLAMP software v9.0 No significant difference between the four splice variants was detected. Sodium current activation began at a potential of approximately -65 mV and the peak current was observed at -25 mV for variants with exon 5A and -20 mV for variants with exon 5N.
The voltage dependent activation of the Na v 1.7 splice variants was assessed from the peak sodium conductance and plotted versus the test voltage ( Figure 2B ). The data were fitted with a Boltzmann function, which enabled us to estimate two important parameters: the midpoint of activation (V 1/2 ) and the slope factor (K v ). There was a small negative shift of about 3 mV in V 1/2 for splice variants with exon 5A compared to Page 12 of 44 13 variants with exon 5N. This shift was significant only between variants 5N11S and 5A11S (P = 0.024, Table 1 ). No significant differences were observed between 5N11S, 5A11L, 5N11L, and 5A11S for K values ( Table 1) . The activation began at -65 mV and was maximal around 0 mV for all variants.
Steady state inactivation was determined by applying a 500 ms pre-pulse to voltages ranging from -150 to -10 mV ( Figure 2C ). The availability determined from the peak current amplitudes of standard test pulses was normalized and plotted versus voltage. The smooth curves of 5N11S, 5A11L, 5N11L, and 5A11S fit a Boltzmann function with midpoints (V 1/2 ) and slope factors (K v ) that were not statistically different (Table 1 ). The inactivation began at about -120 mV and was maximal at -60 mV.
The time courses of current decay of the splice variants elicited at depolarized voltages were fitted using a single exponential function. The resulting time constants 
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The time course of recovery from inactivation of the splice variants ( Figure 4A) was investigated using a double-pulse protocol. Averaged normalized currents evoked by the second depolarization were plotted as a function of the interpulse interval and fit with a single exponential equation. There was no significant difference among the four isoforms in terms of time constants (Table 1) . Maximum recovery was obtained after 100 ms for all the splice variants.
Frequency dependent inhibition was elicited with a train of 50 pulses at different frequencies. Figure 4B shows representative current traces recorded at 5, 50, and 100 Hz.
The 50th pulse was normalized to the first pulse and was plotted against the stimulation frequency ( Figure 4B ). Frequencies superior to 20 Hz induced a marked inhibition of the 50th sweep for all four variants but no significant differences in frequency dependent inhibition were observed.
Na V 1.7 alternative splicing affects the time course for the development of inactivation and slow ramp current amplitude
To investigate the development of inactivation, the cells were stimulated with inactivating pre-pulse potentials of varying durations followed by a test pulse to -20 mV to measure the remaining current (see Material and Methods). Figure 5A shows the average time course for the development of inactivation fitted with a single exponential and obtained for a pre-pulse potential of -80 mV. At this potential, all variants reached steady state inactivation after 500 ms. However, the development of inactivation was significantly (P<0.01, one-way ANOVA) slower for 5A11L and 5A11S than for 5N11S and 5N11L. 5A11L and 5A11S displayed slower inactivation time constants (59.66 ± 6.32 ms, n = 7, and 61.16 ± 4.52 ms, n = 9, respectively) than 5N11S and 5N11L (41.33 ± 3.65 ms, n = 7, and 37.38 ± 4.44 ms, n = 6, respectively). Figure 5B shows the inactivation time constants obtained for each pre-pulse potential tested. As at -80 mV, at -90 mV, the inactivation time constant was significantly slower (P<0.05, one-way ANOVA) for 5A11L and 5A11S splice variants (71.80 ± 6.70 ms, n = 7 and 73.50 ± 6.22 ms, n = 9, respectively) than for 5N11S and 5N11L splice variants (55.12 ± 4.16 ms, n = 7 and 49.79 ± 6.77 ms, n = 6, respectively). For more depolarized potentials (-70 mV and -60 mV), there were no significant differences between exons 5A and 5N.
Differences in the time course for the development of inactivation generate differences in the inward current induced by a slow ramp depolarization (10) . To test this, we used a slow ramp protocol ranging from -140 mV to +20 mV in 500 ms increments to depolarize the cells. Peak ramp currents were expressed as a percentage of the transient peak current amplitudes obtained from the initial I-V curves of single cells ( Figure 5C ).
Interestingly, there were significant exon-5-dependent differences in ramp current amplitudes (P<0.05, one way ANOVA). 5A11L and 5A11S displayed significantly higher ramp currents (1.22 ± 0.24%, n = 7, and 1.25 ± 0.21%, n = 9, respectively) than 5N11S and 5N11L (0.63 ± 0.11 %, n = 10, and 0.73 ± 0.09 %, n = 10, respectively),
indicating that alternative splicing of exon 5 modulates the response of Na v 1.7 to slow ramp current depolarization, with exon 5A inducing larger ramp currents than exon 5N. Figure 5D shows representative traces obtained during slow depolarization (0.32 mV/ms) of the membrane potentials of 5N11S and 5A11S. The ramp current activated near -75 mV for all variants and no significant differences in the peak ramp current potentials of Most of the biophysical properties of the four splice variants were similar.
However, alternative splicing of exon 5 appeared to modulate the development of inactivation for negative potentials. As a consequence, current amplitudes evoked with slow ramp depolarization were also modulated.
Na v 1.7 splice variants exhibit different sensitivities to 8Br-cAMP
Exon 11 is located in the intracellular loop between domains I and II of Na v 1.7, a region of importance for phosphorylation by protein kinase A (PKA). We thus investigated the effects of 8Br-cAMP, a PKA activator, on the Na v 1.7 splice variants by treating the cells for 15 min with 1 mM 8Br-cAMP. Figure 6A shows the effect of 1 mM 8Br-cAMP on the current-voltage relationships obtained for 5N11S and 5N11L. While 8Br-cAMP had no significant effect on 5N11L, the 5N11S isoform was significantly affected (P<0.01, Student's t-test), undergoing a 10 mV shift in peak current to a more hyperpolarized potential. 8Br-cAMP induced a significant 8 mV shift in the midpoint of activation (V 1/2 ) of 5N11S to more negative potentials compared to the control without 8Br-cAMP (P<0.01, Student's t-test) but had no effect on the slope factor (K v ) ( Figure 6B , Table 1 ). No significant difference was observed in the V 1/2 and K v of 5N11L in the presence or absence of 8Br-cAMP (Table 1) . However, it caused a significant (P<0.01, Student's t-test) 5 mV negative shift in the V 1/2 of activation of 5A11S in the presence of 8Br-cAMP compared to the control,
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17 but had no effect on the K v of activation ( Table 1) . As with 5N11L, the V 1/2 and K v of activation of 5A11L was not significantly affected by the presence or absence of 8Br-cAMP (Table 1) .
8Br-cAMP had no effect on the steady state of inactivation of 5N11S, 5A11L, 5N11L, and 5A11S determined by applying a 500 ms pre-pulse to voltages ranging from -150 to -10 mV ( Figure 6C , Table 1 ). Similarly, 8Br-cAMP had no effect on the recovery from inactivation of the four splice variants (Table 1) .
To determine whether the shift in activation was associated with a variation in current amplitude, 8Br-cAMP was applied to cells with a perfusion system. This allowed us to monitor changes in current amplitudes over time. The current variation, after 15 min of 8Br-cAMP perfusion, expressed in percentage of the initial control current amplitude recorded before 8Br-cAMP perfusion was -4.7 ± 4.5 % (5N11S, n = 4) and -2.9 ± 2.1 % (5N11L, n = 3) and was not significant. Therefore, 8Br-cAMP treatments didn't change significantly maximum current amplitude of 5N11S and 5N11L splice variants. Figure   6D shows typical current-voltage relationships obtained for 5N11S before (perfusion of control solution) and after 15 min of 1 mM of 8Br-cAMP perfusion.
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Discussion
Alternative splicing is a common mechanism to generate functionally diverse protein isoforms from a single genetic locus. Several members of the voltage-gated sodium channel family have been shown to be alternatively spliced in different tissues and species (13; 20; 26; 33; 36) . In the present study, we showed that alternatively spliced variants of the human Na v 1.7 channel (5N11S, 5A11L, 5N11L, and 5A11S) can have different functional properties.
In our study, most of the biophysical properties of Na v 1.7 splice variants were very similar. The change of two amino acids in the S3 domain I (exons 5A and 5N;
D1S3:L201V and D1S3:N206D, respectively) induced a small 3 mV shift of activation to more hyperpolarized potentials for exon 5A compared to exon 5N. However, this shift was significant only between 5N11S and 5A11S splice variants. Since this difference was not significant for other variants, it is possible to say that alternative splicing of exon 5 has no effect on activation parameters of human Na v 1.7. Variants of exon 11 had no significant differences in activation parameters. Alternative splicing of exon 5 and exon 11 had no significant effects on the steady state inactivation, inactivation kinetics for depolarized potentials and deactivation time constants. These results are in agreement with the study of Thimmapaya et al., on the Na v 1.3 channel (37). Indeed, these authors investigated the functional properties of Na v 1.3 exon 12 splice variants, which are very similar to those of Nav1.7 exon 11 splice variants. They observed minimal differences (2 mV) in the activation parameters of the isoforms and no differences in inactivation parameters. Our results are also in agreement with those of Dietrich et al., (12) , who studied exon 12 (which corresponds to exon 11 of Na v 1.7) splice variants of Na v 1.6. They observed no significant differences in steady-state activation and steady-state inactivation parameters. However, the insertion of amino acids (corresponding to exon 11L of Na v 1.7)
resulted in a faster time constant of inactivation for depolarized potentials and a faster recovery from inactivation than the other isoform. In our study, we did not see these differences. In fact, the splice variants in our study with an 11-amino-acid insertion in exon 11 displayed similar recoveries from inactivation, which is in agreement with the observations of Thimmapaya et al. (37) . Moreover, in our experiments, there were no significant differences in the frequency dependent inhibition of the Na v 1.7 splice variants.
While alternative splicing did not seem to affect most of biophysical properties of Na v 1.7, the development of inactivation at polarized potentials was significantly slower for variants with exon 5A than those with exon 5N. This difference was related to the higher current elicited by slow ramp depolarization in splice variants containing exon 5A. The link between a slower development of inactivation for negative potentials and a larger slow ramp current amplitude has also been reported (10) . In this paper on Na v 1.4 and Na v 1.7, Cummins et al. (10) showed that Na v 1.7 produced a larger slow ramp current than Na v 1.4. They proposed that this difference was a consequence of a slower development of inactivation for Na v 1.7. This hypothesis was confirmed by the use of divalent cations like Cd 2+ and Zn 2+ that slowed the development of inactivation and also increased ramp current for Na v 1.7 but not for Na v 1.4. In our study, channels with exon 5A inactivate more slowly at negative potentials than channels with exon 5N, causing a delay in inactivation for 5A variants compared to 5N during a slow depolarisation ramp protocol. As a consequence, fewer channels are inactivated at the potential range where 20 the inward current is present. This increase in channels availability will therefore induce larger inward current amplitudes. In our study, peak ramp currents were approximately -55 mV, which is close to the resting potential of DRG neurons (42). Larger ramp current amplitudes might thus increase cell excitability by boosting small stimuli in DRG neurons. Indeed, several studies on Na v 1.7 mutations in erythermalgia have correlated a larger ramp current amplitude with an increase in DRG excitability (9; 18; 19; 21; 31) . In our study, Na v 1.7 channels containing exon 5A displayed a larger ramp current than those containing exon 5N. Mutations involved in erythermalgia that increase the ramp current might thus be more harmful in the presence of exon 5A. Interestingly, symptoms of primary erythermalgia arise in childhood or adolescence and may progress and become constant with age (14; 22). In Na v 1.2, 1.3, 1.5, exon 5N is the neonatal isoform and is replaced progressively with age by exon 5A (7; 17; 27; 32). If, like Na v 1.2, 1.3, and 1.5, exon 5 variants of Na v 1.7 are developmentally regulated, the increased symptoms of erythermalgia with age might be related to an increase in the proportion of exon 5A.
Similarly, changes in the proportions of exons 5N and 5A with age might also be related to differences in pain sensitivity. However, the developmental regulation of exon 5 variants of Na v 1.7 has never been studied and would be of great interest.
The biophysical properties of Na v 1.7 were not affected by the alternative splicing of exon 11, which is located in the intracellular loop between domains I and II. This region possesses several PKA phosphorylation sites and is therefore important in sodium channel modulation (4; 6; 24; 34). cAMP-dependent phosphorylation of the four Na v 1.7
isoforms revealed that the activation and steady-state inactivation of the exon 11L splice variants were not affected by 8Br-cAMP while the activation of the exon 11S isoforms was strongly affected, with a significant shift to hyperpolarized potentials (5 to 8 mV).
Steady-state inactivation, however, was not affected. The insertion of the 11-amino-acid sequence (VIIDKATSDDS) in the intracellular loop between domains I and II thus suppressed the effects of 8Br-cAMP. The cAMP-mediated PKA phosphorylation of rat Na v 1.7 in Xenopus oocytes decreases the peak current without changing the gating properties of the channel (39) . However, the rat Na v 1.7 isoform used by Vijayaragavan et al. (39) contained the 11-amino-acid insertion, which might explain why there was no cAMP-mediated effect on gating. In our study, we studied the effect of 8Br-cAMP on current amplitude using a perfusion system. The shift in activation was not associated with a change in the maximum current amplitude at peak potential. Similarly, there was no significant change in current amplitude for the 11L splice variants. The mechanism involved in the disruption of the cAMP effect by the insertion of these 11 amino acid residues remains to be elucidated. It is possible that the insertion has a major effect on the structure of the intracellular loop and thus significantly changes the availability of potential phosphorylation sites. A second possibility is that another protein is involved in the cAMP effect. One candidate could be an A Kinase-anchoring protein like AKAP-15.
Indeed, AKAP-15 has been shown to be essential for PKA mediated sodium channel phosphorylations and to interact with the cytoplasmic loop connecting transmembrane domains I and II (3; 4; 15; 38) . In a recent study, the binding site of AKAP-15 was identified to be a modified leucine zipper motif localized at the beginning of the intracellular loop between transmembrane domains I and II of Na v 1.2 (15) . Whereas this binding motif is not localized within exon 11, the incorporation of the 11 amino acid residues might change the conformation of the intracellular loop and thus disrupt the binding site of AKAP-15. In these conditions, PKA mediated phosphorylation could be unsettled. This might explain the absence of effects of 8Br-cAMP observed on splice variants that contain exon 11L.
There is increasing evidence in the literature that Na v 1.7 plays a critical role in pain, as in erythromelalgia (9-11; 18; 21; 31; 41) and in diseases involving a complete inability to sense pain (1; 8), indicating that changes in the activity of this channel might have a significant impact on pain sensitivity. The splice variants of Na v 1.7 have been detected in human DRG neurons (30) . In this study, the authors investigated the relative proportions of these variants in a rat model of neuropathic pain. They observed a significant change in the expression pattern of alternatively spliced isoforms. Exon 11S-containing transcripts increased in relative abundance in response to neuropathic injury, indicating that the exon 11S isoform may be involved in pain generation. While we observed no biophysical differences between the exon 11S and 11L splice variants, the activation of the exon 11S isoforms was significantly and negatively shifted in the presence of cAMP, whereas this messenger had no effect on channels containing exon 11L. This might explain the correlation between neuronal hyperexcitability and an increase in expression of exon 11S-containing channels. Interestingly, the cAMP-PKA pathway has little effect on the excitability of intact DRG neurons in uncompressed ganglia (35; 42) . However, these authors also reported that cAMP significantly increases neuronal hyperexcitability by decreasing the action potential threshold in a rat pain model created by the chronic compression of DRG neurons. This is in agreement with the findings of the present study and with the observations of Raymond et al. (30) . During neuropathic pain, an increase in cAMP combined with an increase in exon 11S Na v 1.7 Time constant for tail current deactivation at repolarization potentials ranging from -100
to -40 mV for 5N11S (n = 15), 5A11L (n = 9), 5N11L (n = 12), and 5A11S (n = 7) (see 
